[L-dopa effectiveness decreases over time. What helps Parkinson patients stay mobile?].
Wedekind
Silke
S
D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015259:Dopamine Agents / Q000008:administration & dosage* / Q000009:adverse effects; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects*; D008134:Long-Term Care; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
D000978:Antiparkinson Agents; D015259:Dopamine Agents; D007980:Levodopa